Global herbal medicine industry expected to reach $178.4 billion by 2026

Global Proteomics Market Report 2022: Growing Interest in Personalized Medicine to Drive the Industry

Dublin, Sept. 22, 2022 (GLOBE NEWSWIRE) — The ‘Proteomics – Global Market Trajectory & Analytics’ report has been added to from ResearchAndMarkets.com offer.

Global proteomics market to reach $43.5 billion by 2026
Amid the COVID-19 crisis, the global proteomics market estimated at US$30.2 billion in 2022 is expected to reach a revised size of US$43.5 billion by 2026, growing at a CAGR of 10.8% over the analysis period. Reagents, one of the segments analyzed in the report, is expected to grow at a CAGR of 10.6% to reach US$34.8 billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and the induced economic crisis, the growth of the Instruments segment is readjusted to a revised CAGR of 11.8% for the next 7-year period. This segment currently represents a 17.2% share of the global proteomics market.

The US market is estimated at $11.5 billion in 2022, while China is expected to reach $3.9 billion by 2026

The proteomics market in the United States is estimated to be worth US$11.5 billion in 2022. The country currently accounts for a 37.7% share of the global market. China, the world’s second largest economy, is expected to reach an estimated market size of US$3.9 billion in 2026, growing at a CAGR of 13.6% over the analysis period. Other noteworthy geographic markets include Japan and Canada, each forecasting growth of 9.2% and 10.1% respectively over the analysis period. In Europe, Germany is expected to grow at a CAGR of approximately 10.3%, while the rest of the European market (as defined in the study) will reach US$4.3 billion by the end of the forecast period. ‘to analyse.

Major driving factors for market growth include increasing demand for personalized medicine, growing applications of proteomics in drug discovery, increasing demand for early diagnosis and treatment of diseases, technical advancements, increase in congenital disorders and genetic disorders and the rapid growth of pharmaceuticals and pharmaceuticals. biopharmaceutical markets.

Other factors supporting growth include the development of protein-targeted treatments and molecular precision drugs for many autoimmune diseases, the development of mass spectrometry-based proteomics, and the development of molecular targets in tumors. malignant.

Select contestants (178 total featured):

  • ActivX Biosciences, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cytiva
  • Geneva Bioinformatics SA
  • Merck KGaA
  • PerkinElmer, Inc.
  • Shimadzu Company
  • Millipore Sigma
  • ThermoFisher Scientific, Inc.
  • Waters Corp.
  • Xencor, Inc.

Main topics covered:

I. METHODOLOGY

II. ABSTRACT

1. MARKET OVERVIEW

2. FOCUS ON CERTAIN PLAYERS

3. MARKET TRENDS AND DRIVERS

  • Proteomics profiling to accelerate drug discovery
  • Other applications of proteomics in drug discovery
  • Novel proteomics technique to facilitate drug screening and biomarker discovery
  • Growing Interest in Personalized Medicine to Drive Market Growth
  • Oncology: a key area for proteomics
  • Proteomics approaches are gaining importance in cancer drug discovery
  • Proteomics technologies used in cancer drug discovery and development
  • Role of proteomics in the discovery of biomarkers in oncology
  • List of FDA-approved protein biomarkers for cancer
  • Advances in proteomics put biomarkers in the limelight
  • Different types of SP-based proteomic discovery techniques for biomarkers
  • Techniques based on affinity reagent matrices
  • Affinity and antibody-based MS techniques
  • CE-MS technology: an emerging technology for biomarker discovery
  • Protein chips: a new tool for the development of pharmaceutical products
  • New technologies expand the application of proteomics
  • DIA technique for protein discovery
  • AI and machine learning bridge gaps in traditional equipment to efficiently identify protein patterns
  • Bioinformatics tools combined with proteomics accelerate the process of pathway prediction
  • Map of COVID-19 human protein interactions reveals drug targets
  • Single-cell proteomics offers a better understanding of cell identity
  • Metalloproteomics: a rapidly evolving field
  • Post-translational modification of proteins increases the functional diversity of the proteome
  • Pharmacoproteomics offers important perspectives in precision medicine
  • Growing Importance of Nanoproteomics Expands Opportunities

4. GLOBAL MARKET OUTLOOK

III. MARKET ANALYSIS

IV. COMPETITION

Companies cited

  • ActivX Biosciences, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cytiva
  • Geneva Bioinformatics SA
  • Merck KGaA
  • PerkinElmer, Inc.
  • Shimadzu Company
  • Millipore Sigma
  • ThermoFisher Scientific, Inc.
  • Waters Corp.
  • Xencor, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/8ghqd1

  • Global proteomics market

        

#Global #Proteomics #Market #Report #Growing #Interest #Personalized #Medicine #Drive #Industry

Leave a Comment

Your email address will not be published.